Acutaas Chemicals Ltd.
ACUTAAS.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
Share Statistics
| Market cap | - |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 22.58% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | - |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 24, 2026
EPS Estimate
$9.35
Average shareholder expectationRevenue Estimate
$3.27 B
Average shareholder expectationNext Earnings Call
Expected Date
November 14, 2026
EPS Estimate
$11.10
Average shareholder expectationRevenue Estimate
$3.70 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Acutaas Chemicals Limited
1,007 employees
CEO: Nareshkumar Ramjibhai Patel Headquartered in Surat, India, Acutaas Chemicals Limited, founded in 2004, operates internationally in the research, development, manufacturing, and distribution of pharmaceutical intermediates. These essential chemical building blocks a...